mail-order mifepristone – Danco Laboratories asks the Supreme Court to pause a ruling that blocks mail-order dispensing of mifepristone, citing patient harm and chaos.
A pharmaceutical company is urging the Supreme Court to step in quickly to prevent a new ruling from disrupting mail-order access to the abortion pill mifepristone.
In an emergency request filed with the court, Danco Laboratories asked justices to lift a decision from the U.S.. Court of Appeals for the 5th Circuit that bars health providers from dispensing mifepristone by mail.. The company warned that the immediate implementation of the ruling is creating uncertainty for manufacturers. distributors. pharmacies. providers. and patients across the country.
The request also argues that this kind of disruption amounts to “irreparable harm. ” emphasizing how fast-changing rules can complicate care that depends on timely scheduling and access.. While litigation continues. the lower court’s order is set to take effect immediately and temporarily blocks FDA guidance tied to earlier federal efforts to ease access.
This matters because medication access is often governed by logistics as much as legal decisions. When court orders change quickly, patients and pharmacies can be left scrambling to determine what is allowed in each state and on each timeline.
Danco’s filing comes as federal abortion medication access remains a major flashpoint in U.S.. politics and courts.. The company’s motion points to the way ongoing litigation has unfolded. including the Supreme Court’s prior refusal to revive a similar challenge two years ago. when the justices concluded the parties bringing the case did not have standing.
In the latest emergency filing, Danco is also challenging the underlying effort to bring the case, which is led by Louisiana. The company contends that Louisiana is not directly affected by the FDA’s approval decisions and therefore should not be able to pursue the legal challenge.
The company further argues that the current ruling reaches beyond a typical pause and effectively interferes with a distribution system that has been used for years. warning that the situation could force patients to seek urgent in-person appointments on short notice.. The request asks both for a stay of the lower court’s decision and for the Supreme Court to consider the case more broadly.
Meanwhile. the case is being handled initially in connection with Justice Samuel Alito because the dispute stems from the 5th Circuit. though he may route the matter to the full court for consideration.. Louisiana’s attorney general, Liz Murrill, said she expects to continue defending the lawsuit as it moves forward.
At the heart of the dispute is a question that extends beyond one state: how quickly the federal judiciary can alter the availability of a widely used medication, and what that speed means for medical planning and public reliance on established processes.